Financial Performance - Revenue for Q2 2021 was $160.5 million, a 91% increase year-over-year compared to $84.0 million in Q2 2020[7] - Adjusted EBITDA for Q2 2021 was $14.5 million, a 39% increase year-over-year compared to $10.5 million in Q2 2020[7] - The company has a strong balance sheet with a cash position of $276 million[7] - TTM (Trailing Twelve Months) Revenue is $524 million[8] Growth and Expansion - Total clinicians reached 3,975, up 94% year-over-year, with 674 net clinician additions in Q2 2021[7] - The company operates in 31 states with 450+ centers[10, 16, 18] - 35 de novo centers were opened in Q2 2021, part of 183 opened since inception[16] - 10 acquisitions were completed in Q2 2021, part of 64 acquisitions completed since inception[16] Market and Strategy - The company is well-positioned for continued market share gains in the $116 billion mental health market[10] - The company estimates the total addressable market (TAM) will grow to $215 billion by 2025, representing a 14% CAGR (Compound Annual Growth Rate)[17] Social Responsibility - The LifeStance Health Foundation was established with an initial endowment of $10 million[7, 13]

LifeStance Health Group, Inc. (NASDAQ:LFST) Q2 2021 Earnings Conference Call August 11, 2021 5:00 PM ET Company Participants Michael Lester - Chief Executive Officer Danish Qureshi - Chief Growth Officer Mike Bruff - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Ryan Daniels - William Blair Lisa Gill - JPMorgan Steph Wissink - Jefferies Jamie Perse - Goldman Sachs Operator Good afternoon everyone and welcome to LifeStance Health Second Quarter 2021 Conference Call. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40478 LifeStance Health Group, Inc. (Exact Name of Registrant as Specified in its Charter) | Delaware | 86-1832801 | | --- | --- | ...